Researchers deployed an OpenAI reasoning model to assist in diagnosing rare genetic diseases affecting children, successfully identifying 18 new diagnoses in cases that had previously stumped traditional medical workups. The AI system helped clinicians narrow differential diagnoses by synthesizing complex genetic and clinical data that would be time-prohibitive for humans to manually review.

This proof-of-concept demonstrates AI's potential in medical settings where rare conditions are hard to recognize and early diagnosis is critical for treatment outcomes.

What This Means for Your Business

If you work in healthcare IT, diagnostics, or medical research, this signals a genuine clinical use case for AI that insurers and hospital systems are beginning to fund. Consider how your organization might integrate reasoning models into rare disease registries or genetic counseling workflows—payers are increasingly interested in tools that reduce diagnostic delays and improve patient outcomes.